Tatsuya Yoshizawa

Prof. Dr. Tatsuya Yoshizawa


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
MFMasatoshi Fukuda
Masatoshi Fukuda
TYTatsuya Yoshizawa
Tatsuya Yoshizawa
FKFazlul Karim
Fazlul Karim
SSShihab U. Sobuz
Shihab U. Sobuz
WKWataru Korogi
Wataru Korogi
KYKazuya Yamagata
Kazuya Yamagata
SP7/Osterix (OSX) is a master regulatory transcription factor that activates a variety of genes during differentiation of osteoblasts. However, the influence of post-translational modifications on the regulation of its transactivation activity is largely unknown. Here, we report that sirtuins, which are NAD(+)-dependent deacylases, regulate lysine deacylation-mediated transactivation of OSX. Germline Sirt7 knockout mice develop severe osteopenia characterized by decreased bone formation and an increase of osteoclasts. Similarly, osteoblast-specific Sirt7 knockout mice showed attenuated bone formation. Interaction of SIRT7 with OSX leads to the activation of transactivation by OSX without altering its protein expression. Deacylation of lysine (K) 368 in the C-terminal region of OSX by SIRT7 promote its N-terminal transactivation activity. In addition, SIRT7-mediated deacylation of K368 also facilitates depropionylation of OSX by SIRT1, thereby increasing OSX transactivation activity. In conclusion, our findings suggest that SIRT7 has a critical role in bone formation by regulating acylation of OSX.

1 September 2020 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YKYuichi Kariba
Yuichi Kariba
TYTatsuya Yoshizawa
Tatsuya Yoshizawa
YSYoshifumi Sato
Yoshifumi Sato
TTTomonori Tsuyama
Tomonori Tsuyama
EAEiichi Araki
Eiichi Araki
KYKazuya Yamagata
Kazuya Yamagata

12 December 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
TYTatsuya Yoshizawa
Tatsuya Yoshizawa
YSYoshifumi Sato
Yoshifumi Sato
SSShihab U. Sobuz
Shihab U. Sobuz
TMTomoya Mizumoto
Tomoya Mizumoto
TTTomonori Tsuyama
Tomonori Tsuyama
KYKazuya Yamagata
Kazuya Yamagata
Brown adipose tissue plays a central role in the regulation of the energy balance by expending energy to produce heat. NAD+-dependent deacylase sirtuins have widely been recognized as positive regulators of brown adipose tissue thermogenesis. However, here we reveal that SIRT7, one of seven mammalian sirtuins, suppresses energy expenditure and thermogenesis by regulating brown adipose tissue functions. Whole-body and brown adipose tissue-specific Sirt7 knockout mice have higher body temperature and energy expenditure. SIRT7 deficiency increases the protein level of UCP1, a key regulator of brown adipose tissue thermogenesis. Mechanistically, we found that SIRT7 deacetylates insulin-like growth factor 2 mRNA-binding protein 2, an RNA-binding protein that inhibits the translation of Ucp1 mRNA, thereby enhancing its inhibitory action on Ucp1. Furthermore, SIRT7 attenuates the expression of batokine genes, such as fibroblast growth factor 21. In conclusion, we propose that SIRT7 serves as an energy-saving factor by suppressing brown adipose tissue functions.

25 December 2023 in Cells
Verified
Journal Article
Open access
PDF file
KYKazuya Yamagata
Kazuya Yamagata
TMTomoya Mizumoto
Tomoya Mizumoto
TYTatsuya Yoshizawa
Tatsuya Yoshizawa
Sirtuins (SIRT1–7 in mammals) are a family of NAD+-dependent lysine deacetylases and deacylases that regulate diverse biological processes, including metabolism, stress responses, and aging. SIRT7 is the least well-studied member of the sirtuins, but accumulating evidence has shown that SIRT7 plays critical roles in the regulation of glucose and lipid metabolism by modulating many target proteins in white adipose tissue, brown adipose tissue, and liver tissue. This review focuses on the emerging roles of SIRT7 in glucose and lipid metabolism in comparison with SIRT1 and SIRT6. We also discuss the possible implications of SIRT7 inhibition in the treatment of metabolic diseases such as type 2 diabetes and obesity.

6 May 2021 in Journal of Diabetes Investigation
Verified
Journal Article
Open access
PDF file
FAFatema Akter
Fatema Akter
TTTomonori Tsuyama
Tomonori Tsuyama
TYTatsuya Yoshizawa
Tatsuya Yoshizawa
SSShihab U. Sobuz
Shihab U. Sobuz
KYKazuya Yamagata
Kazuya Yamagata
Aims/Introduction: Peroxisome proliferator‐activated receptor (PPAR)‐γ2 is a transcription factor crucial for regulating adipogenesis and glucose/lipid metabolism, and synthetic PPARγ ligands, such as thiazolidinediones, are effective oral medication for type 2 diabetes. Sirtuin 7 (SIRT7), a nicotinamide adenine dinucleotide‐dependent deacetylase, also controls metabolism. However, it is not known whether SIRT7 regulates the function of PPARγ2 by its deacetylation.Materials and Methods: Physical interaction between SIRT7 and PPARγ2, the effect of SIRT7 on PPARγ2 acetylation, and the deacetylation residue targeted by SIRT7 were investigated. The effects of PPARγ2 K382 acetylation on lipid accumulation, gene expression in C3H10T1/2 cell‐derived adipocytes, and ligand‐dependent transactivation activity were also evaluated.Results: We demonstrated that SIRT7 binds to PPARγ2 and deacetylates PPARγ2 at K382. C3H10T1/2‐derived adipocytes expressing PPARγ2K382Q (a mimic of acetylated K) accumulated much less fat than adipocytes expressing wild‐type PPARγ2 or PPARγ2K382R (a mimic of nonacetylated K). Global gene expression analysis of adipocytes expressing PPARγ2K382Q revealed that K382Q caused the dysregulation of a set of genes involved in lipogenesis, including Srebp1c, Acaca, Fasn, and Scd1. The rosiglitazone‐dependent transcriptional activity of PPARγ2K382Q was reduced compared with that of PPARγ2K382R.Conclusion: Our findings indicate that SIRT7‐dependent PPARγ2 deacetylation at K382 controls lipogenesis in adipocytes.

Verified
Journal Article
Open access
PDF file
HMHironori Mizutani
Hironori Mizutani
YSYoshifumi Sato
Yoshifumi Sato
MYMasaya Yamazaki
Masaya Yamazaki
TYTatsuya Yoshizawa
Tatsuya Yoshizawa
YAYusuke Ando
Yusuke Ando
KYKazuya Yamagata
Kazuya Yamagata
Alzheimer’s disease (AD) is an age-related neurodegenerative disease that is characterized by irreversible memory loss and cognitive decline. The deposition of amyloid-β (Aβ), especially aggregation-prone Aβ42, is considered to be an early event preceding neurodegeneration in AD. Sirtuins (SIRT1–7 in mammals) are nicotinamide adenine dinucleotide-dependent lysine deacetylases/deacylases, and several sirtuins play important roles in AD. However, the involvement of SIRT7 in AD pathogenesis is not known. Here, we demonstrate that SIRT7 mRNA expression is increased in the cortex, entorhinal cortex, and prefrontal cortex of AD patients. We also found that Aβ42 treatment rapidly increased NADPH oxidase 4 (NOX4) expression at the post-transcriptional level, and induced reactive oxygen species (ROS) production and apoptosis in neuronal SH-SY5Y cells. In contrast, SIRT7 knockdown inhibited Aβ42-induced ROS production and apoptosis by suppressing the upregulation of NOX4. Collectively, these findings suggest that the inhibition of SIRT7 may play a beneficial role in AD pathogenesis through the regulation of ROS production.